Jump to navigation
Gemzoe K, Crawford R, Caress A, Rushton R, Shah A, Collier S, Doward L, Vekaria R, Worsley S, Leather DA. Patient and healthcare professional (HCP; general practitioner [GP] and practice manager [PM]) insights to facilitate engagement in future effectiveness studies: learnings from the Salford Lung Studies (SLS). Poster presented at the 2019 American Thoracic Society (ATS) International Conference; May 22, 2019. Dallas, TX.
Zuluaga Sanchez S, Purser M, Mader G, Gould IG, Knight C, Johnson NB, Patel M, Jensen J, Odom T. Improved quality of life and life-years in patients with infantile-onset SMA following treatment with nusinersen. Poster presented at the ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.
Zuluaga Sanchez S, Purser M, Mader G, Gould IG, Knight C, Patel M, Odom T, Jensen J, Johnson NB. Improved quality of life for patients and caregivers among patients with later-onset SMA following treatment with Nusinersen. Poster presented at the ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.
Carrico J, Jia X, Zhao Y, Zhang J, Brodtkorb TH, Mendelsohn AB, Lowry S, Wu JJ, Feldman SR, Armstrong AW. Budget-impact and cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis from a US health plan perspective. Poster presented at the ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.
Gabriel A, Apostolides J, Nickodem A, Rad AN, Patel V, Zaw R, Martin S, Harris N, Jones G, Nahabedian MY. Patient experience with different implant breast reconstruction surgeries. Poster presented at the ISPOR 24th Annual International Meeting; May 20, 2019. New Orleans, LA.
Paquin RS, Fischer R, Mansfield C, Mange B, Beaverson K, Ganot A, Martin AS, Morris C, Rensch C, Ricotti V, Russo LJ, Sadosky A, Smith EC, Peay H. Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best–worst scaling experiment in caregivers and adult patients. Orphanet J Rare Dis. 2019 May 9;14(1):102. doi: 10.1186/s13023-019-1069-6.
Goyal RK, Cuyun Carter G, Nagar SP, Smyth EN, Price GL, Huang YJ, Li L, Davis KL, Kaye JA. Treatment patterns, survival, and economic outcomes in Medicare-enrolled, older patients with HR+/HER2– metastatic breast cancer. Curr Med Res Opin. 2019 May 7. doi: 10.1080/03007995.2019.1615422.
Peay H, Fischer R, Tzeng JP, Hesterlee SE, Morris C, Martin AS, Rensch C, Smith E, Ricotti V, Beaverson K, Wand H, Mansfield C. Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: a qualitative preference study of patients and parents. PLoS One. 2019 May 1;14(5):e0213649. doi: 10.1371/journal.pone.0213649.
Price M, Ravelo A, Sae-Hau M, Torney PA, Gonzalez V, Weiss ES, Mansfield C, Mange B, Ortiz EC, Masaquel A, Dawson KL. Patient-reported disease burden in chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma: results from a national patient advocacy survey. J Clin Oncol. 2019 May;37:e18198.
Jahn B, Todorovic J, Bundo M, Sroczynski G, Conrads-Frank A, Rochau U, Endel G, Wilbacher F, Malbaski N, Popper N, Chhatwal J, Greenberg D, Mauskopf J, Siebert U. Budget impact analysis of cancer screening: A methodological review. Appl Health Econ Health Policy. 2019 Apr 24. doi: 10.1007/s40258-019-00475-6.